Gene therapy company with operations in KoP files for $100M IPO
The company has raised about $265 million, including $148 million in a Series C round disclosed last month.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ron Leuty Source Type: news